The rise of genome sequencing has opened a new frontier for the issue that could drive divergence of the cancer care received by different races.
Researchers have published the first analysis of the 60,000 people sequenced through the Exome Aggregation Consortium.
The Pfizer study that identified 15 genome sites linked to depression in 23andMe’s database has sparked a surge in demands to access the repository.
Google's Art Levinson-helmed biotech Calico has hired Daphne Koller to build and lead its computational biology and machine learning team.
Researchers at MIT have developed a framework to ensure genetic data can be shared freely without putting individuals’ privacy at risk.
Illumina has tasked FlowJo with developing data analysis software to support its expansion into high-throughput sequencing of single cells.
Pfizer has delivered a clear indication of the research potential of 23andMe’s massive database by finding 15 genetic loci linked to risk of major depression.
Researchers at the U.S. National Institutes of Health have led the development of software to identify sequence-structure binding motifs on aptamers.
The Garvan Institute has founded a whole genome sequencing subsidiary, given it access to an Illumina HiSeq X Ten and tapped DNAnexus for its cloud platform.
N-of-One has raised $7 million to improve its oncology precision medicine system and expand its sales operation globally.